These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33463299)

  • 41. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives.
    Geis NA; Katus HA; Bekeredjian R
    Curr Pharm Des; 2012; 18(15):2166-83. PubMed ID: 22352771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Serum-Resistant Transfection Evaluation and Long-Term Stability of Gene Delivery Dry Powder Based on Mesoporous Silica Nanoparticles and Polyethyleneimine by Freezing-Drying.
    Zhang X; Zhang J; Quan G; Yang P; Pan X; Wu C
    AAPS PharmSciTech; 2017 Jul; 18(5):1536-1543. PubMed ID: 27600322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer.
    Wang DS; Panje C; Pysz MA; Paulmurugan R; Rosenberg J; Gambhir SS; Schneider M; Willmann JK
    Radiology; 2012 Sep; 264(3):721-32. PubMed ID: 22723497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Titania coating of mesoporous silica nanoparticles for improved biocompatibility and drug release within blood vessels.
    Farooq A; Shukur A; Astley C; Tosheva L; Kelly P; Whitehead D; Azzawi M
    Acta Biomater; 2018 Aug; 76():208-216. PubMed ID: 29933106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted delivery of biodegradable nanoparticles with ultrasound-targeted microbubble destruction-mediated hVEGF-siRNA transfection in human PC-3 cells in vitro.
    Li YH; Shi QS; Du J; Jin LF; Du LF; Liu PF; Duan YR
    Int J Mol Med; 2013 Jan; 31(1):163-71. PubMed ID: 23138749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles.
    Zhou Y; Gu H; Xu Y; Li F; Kuang S; Wang Z; Zhou X; Ma H; Li P; Zheng Y; Ran H; Jian J; Zhao Y; Song W; Wang Q; Wang D
    Theranostics; 2015; 5(4):399-417. PubMed ID: 25699099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Site directed vascular gene delivery in vivo by ultrasonic destruction of magnetic nanoparticle coated microbubbles.
    Mannell H; Pircher J; Fochler F; Stampnik Y; Räthel T; Gleich B; Plank C; Mykhaylyk O; Dahmani C; Wörnle M; Ribeiro A; Pohl U; Krötz F
    Nanomedicine; 2012 Nov; 8(8):1309-18. PubMed ID: 22480917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of cationic microbubbles targeted to P-selectin to improve ultrasound-mediated gene transfection of hVEGF
    Shentu WH; Yan CX; Liu CM; Qi RX; Wang Y; Huang ZX; Zhou LM; You XD
    J Zhejiang Univ Sci B; 2018 Sept.; 19(9):699-707. PubMed ID: 30178636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
    Saroj S; Rajput SJ
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for "Self-Actuating" On-Demand Controlled Drug Delivery for Cancer Therapy.
    Vaghasiya K; Ray E; Sharma A; Katare OP; Verma RK
    ACS Appl Bio Mater; 2020 Aug; 3(8):4987-4999. PubMed ID: 35021676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient gene therapy with a combination of ultrasound‑targeted microbubble destruction and PEI/DNA/NLS complexes.
    Wang YJ; Zhou Q; Cao S; Hu B; Deng Q; Jiang N; Cui J
    Mol Med Rep; 2017 Nov; 16(5):7685-7691. PubMed ID: 28944824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles for Efficient Targeting Drug Delivery and Magnetic Resonance Imaging.
    Chen L; Zhou X; Nie W; Zhang Q; Wang W; Zhang Y; He C
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33829-33841. PubMed ID: 27960384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinoma.
    Wang Z; Chang Z; Lu M; Shao D; Yue J; Yang D; Zheng X; Li M; He K; Zhang M; Chen L; Dong WF
    Biomaterials; 2018 Feb; 154():147-157. PubMed ID: 29128843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Facile Strategy to Prepare an Enzyme-Responsive Mussel Mimetic Coating for Drug Delivery Based on Mesoporous Silica Nanoparticles.
    Hu C; Huang P; Zheng Z; Yang Z; Wang X
    Langmuir; 2017 Jun; 33(22):5511-5518. PubMed ID: 28486810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
    Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
    Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.